IL6 and rheumatoid arthritis: RA-FLSs play a central role in disease pathogenesis by becoming activated in response to inflammatory signals and releasing inflammatory mediators, including cytokines (IL-1β, IL-6), together with matrix metalloproteinases (MMPs) that damage extracellular matrix, among others [13,14].